Reuters - Video

Edition: US | UK | IN | CN | JP

video Business

Japan's Takeda takeover bid causes investor headache

Friday, April 20, 2018 - 01:47

Takeda Pharmaceutical shares lost almost 5 percent of their value on Friday as investors fretted over the size of any deal the Japanese firm would have to make after London-listed drugmaker Shire rejected its latest $63 bln bid. As Kate King reports, Botox-maker Allergan has also pulled out of the bidding battle.

▲ Hide Transcript

View Transcript

Takeda Pharmaceutical shares lost almost 5 percent of their value on Friday as investors fretted over the size of any deal the Japanese firm would have to make after London-listed drugmaker Shire rejected its latest $63 bln bid. As Kate King reports, Botox-maker Allergan has also pulled out of the bidding battle.

Press CTRL+C (Windows), CMD+C (Mac), or long-press the URL below on your mobile device to copy the code

Japan's Takeda takeover bid causes investor headache

Friday, April 20, 2018 - 01:47